Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis.
By M. Semkovska, D. McLoughlin. Biological Psychiatry, 2010
658 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/2be06c86948bdeebdc97366e96601652a170e4e0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
In Psychiatry and Mental health
Citations in the corpus
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015, methodology): “A meta-analysis (Semkovska and McLoughlin, 2010) of 24 cognitive variables measured across 84 studies (2981 patients) found significant decreases in cognitive performance 0–3 days after ECT in 72% of variables (ES ranging from 1.”
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016, background): “Table 6 summarizes the recommendations for delivery of ECT.”
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “Anterograde memory changes generally return to normal or may be improved compared to pre-ECT levels within 2–4 weeks (Semkovska and McLoughlin, 2010) but retrograde impairment, which is more likely with bitemporal placement, can persist for prolonged periods (Sackeim et al.”